The companies — Rosetta Genomics, MDRNA, and Tekmira Pharmaceuticals — have all seen their shares more than double since Dec. 31, significantly outperforming the Nasdaq Biotechnology Index.
Included are a large-scale study of the human kinome, and a description of a database combining ETD spectra and protein sequence databases for peptide identification.
A separate deal under which Prometheus agreed to acquire 2 million shares of Rosetta at $4 per share has also been completed.
The system, which serves California's largest public healthcare district, is offering 23andMe's service at several outpatient centers in an effort to advance preventative care.
The university's new labs will conduct an array of 'omics studies of cancer, addiction, infection, and others.
Matrix Genomics' DNA home testing kits for Alzheimer's disease, breast cancer, and heart attack risk
More and more research is linking CNVs to disease. It's not only changing the way scientists study disease, but also how clinicians diagnose it.
The university will compare the genomes of dyslexic and non-dyslexic people to study language gene interactions and develop a diagnostic test.
PGx & molecular Dx
The US National Institutes of Health's All of Us project awarded $4.6 million to the company Color to develop a genetic counseling resource for the program.
The Times of India reports on a pilot study that used genomic testing to determine whether patients had drug-resistant tuberculosis.
New guidelines say that more women may benefit from genetic testing for hereditary breast or ovarian cancer, according to the Los Angeles Times.
In Cell this week: small proteins identified among human microbiome, role for tumor microbes in pancreatic cancer survival, and more.